Yahoo Finance

Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)

Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price "We are proud to now offer Sotyktu at a lower price via ...
Yahoo Finance

A Fresh Look at Bristol Myers Squibb’s Valuation Following Its Patient Connect Expansion and Drug Discount Initiative

If you have been keeping an eye on Bristol-Myers Squibb (BMY), you may have noticed recent buzz surrounding its newest move: an expansion of its direct-to-patient Patient Connect platform. The company ...
Morningstar

Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)

Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price Bristol Myers Squibb (NYSE: BMY) today announced an ...